↓ Skip to main content

The Who, What, and Why of Drug Discovery and Development

Overview of attention for article published in Trends in Pharmacological Sciences, September 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)

Mentioned by

twitter
6 X users

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Who, What, and Why of Drug Discovery and Development
Published in
Trends in Pharmacological Sciences, September 2018
DOI 10.1016/j.tips.2018.08.002
Pubmed ID
Authors

Glenn Hogan, Mark Tangney

Abstract

Inquiry into declining pharmaceutical R&D efficiency has focussed on 'what' can be improved, with only brief thought given to 'who' can be improved. Here, we argue that enabling people in the idea-to-product chain to have a more holistic knowledge of the behaviours and incentives of each other can optimise R&D.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 15%
Student > Ph. D. Student 6 13%
Other 5 10%
Researcher 4 8%
Student > Bachelor 3 6%
Other 9 19%
Unknown 14 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 23%
Medicine and Dentistry 5 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Business, Management and Accounting 4 8%
Agricultural and Biological Sciences 2 4%
Other 7 15%
Unknown 15 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2018.
All research outputs
#8,266,724
of 25,385,509 outputs
Outputs from Trends in Pharmacological Sciences
#1,256
of 2,406 outputs
Outputs of similar age
#133,927
of 345,662 outputs
Outputs of similar age from Trends in Pharmacological Sciences
#14
of 19 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 2,406 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.1. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,662 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.